GlobeNewswire by notified

Acron Group’s IFRS EBITDA Triples in 9M 2021


29 November 2021

Acron Group’s IFRS EBITDATriples in 9M 2021

Today, Acron Group (Moscow Exchange and LSE: AKRN) released its consolidated IFRS financial statements for 9M 2021.

Key Financials

  • Revenue was up 59% year-on-year to RUB 137,215 million (9M 2020: RUB 86,088 million). In US dollar equivalent, revenue was up 52% to USD 1,854 million from USD 1,216 million.
  • EBITDA* increased by a factor of 2.9 year-on-year to RUB 69,185 million (9M 2020: RUB 24,116 million). In US dollar equivalent, EBITDA increased by a factor of 2.7 to USD 935 million from USD 341 million.
  • EBITDA margin was up to 50%, against 28% year-on-year.
  • Net profit was RUB 50,934 million, against a loss of RUB 4,161 million year-on-year. In US dollar equivalent, net profit was USD 688 million.
    • Net debt was down 26% to RUB 74,022 million, against RUB 99,579 million as of 31 December 2020. In US dollar equivalent, net debt was down 25% to USD 1,017 million from USD 1,348 million.
    • Net debt/LTM EBITDA** denominated both in roubles and US dollars was 0.9, down from 2.8 as of 31 December 2020.

Operating Results

  • Output of key products was 6.315 million tonnes, up 6% year-on-year.
  • Sales of key products totalled 6.188 million tonnes, up 4% year-on-year.

Alexander Popov, Chairman of the Acron Board of Directors, commented on the results:

‘We are pleased to present Acron Group’s record-breaking financials. In 9M 2021, the Group's EBITDA increased by a factor of 2.7 year-on-year to USD 935 million. EBITDA margin increased from 28% to 50%. The Group reduced its debt burden. The net debt/EBITDA ratio at the end of the reporting period was 0.9, down from 2.8 as of 31 December 2020.

‘Acron Group is a responsible producer that has always prioritised the domestic market, even as global prices continue to rise. In July 2021, the Group and other top fertiliser producers voluntarily agreed to fix domestic prices till the year-end and in November extended the freeze till the end of the spring sowing season to ensure that their products are affordable for Russian growers.. Deliveries have been made in full.

‘We are taking advantage of a lower debt burden to gradually accelerate capital expenditures. The active phase of the Talitsky potash project is underway: we are purchasing major equipment and conducting construction and installation operations for the project’s surface and underground facilities and infrastructure.

‘Our chemical division has an investment programme through 2023 that includes highly effective brownfield projects. We are already exploring both brownfield and greenfield projects for the next investment cycle based on their anticipated impact on the Group’s ESG agenda and carbon footprint’.


Notes on Key Items in the Financial Statements

Financial Performance

In 9M 2021, several factors drove Acron Group’s revenue up 59% year-on-year to RUB 137,215 million, including 4% higher sales of the Group’s key products, growing global dollar–denominated prices for mineral fertilisers, and a 5% increase in the average USD–RUB exchange rate.

Average Indicative Prices, FOB Baltic Sea/Black Sea

USD/t9M 20219M 20209M 2021/9M 2020
NPK 16-16-1636625444%

In the reporting period, the cost of sales was up 5% year-on-year to RUB 49,770 million, mainly due to higher sales and prices for potash and the increased cost of the mineral extraction tax on phosphates, which were significantly offset by reduced depreciation and amortisation and a decline in expenses for third–party services related to rock mined at Oleniy Ruchey.

Selling, general, and administrative expenses were up 9% to RUB 7,072 million, mainly due to higher personnel costs.

Transportation expenses were up 20% to RUB 20,227 million, driven by increased sales, higher freight and container–shipping rates denominated in US dollars, and higher logistics costs outside Russia due to a weaker rouble. Increased sales to Latin America on terms including transportation also contributed to the change in this item.

EBITDA increased by a factor of 2.9 to RUB 69,185 million, and the Group’s EBITDA margin reached 50%, against 28% in 9M 2020. EBITDA margin was 52% at the Group’s Acron facility in Veliky Novgorod, 46% at Dorogobuzh, and 47% at NWPC.

In the reporting period, the Group posted a net exchange profit of RUB 1,990 million from revaluation of assets, loans, and liabilities, against a loss of RUB 15,763 million in 9M 2020. Financial derivatives generated a gain of RUB 4,919 million, against a loss of RUB 2,551 million in 9M 2020.

Net profit in the reporting period was RUB 50,934 million, against a loss of RUB 4,161 million in 9M 2020.

Cash Flow

In 9M 2021, net operating cash flow increased by a factor of 4.6 to RUB 41,241 million from RUB 8,949 million in 9M 2020 because of an increase in net profit. Working capital reached RUB 13,438 million in 9M 2021, up from RUB 10,649 million in 9M 2020.

Net cash used in investing activities in 9M 2021 was up 16% to RUB 12,262 million from RUB 10,558 million in 9M 2020. Capital expenditures increased 21% year-on-year to RUB 14,107 million from RUB 11,667 million in 9M 2020. In dollar equivalent, capital expenditures were USD 191 million, against USD 165 million in 9M 2020.

In the reporting period, net cash used in financial activities was RUB 28,006 million, against RUB 7,861 million generated by the Group’s financing activities in 9M 2020. Cash outflow in the reporting period mainly consisted of RUB 23,117 million in repaid net borrowings, while cash inflow in 9M 2020 resulted from net borrowings of RUB 30,783 million.

Debt Burden

As of the end of the reporting period, total debt was RUB 90,279 million, down 22% from RUB 115,116 million on 31 December 2020. In US dollar equivalent, total debt was USD 1,241 million, down 20% from USD 1,558 million as of the end of 2020. The share of long–term debt increased from 68% to 91%.

Net debt as of the end of 9M 2021 was RUB 74,022 million, down 26% from RUB 99,579 million as of 31 December 2020. In US dollar equivalent, net debt was USD 1,017 million, down 25% from USD 1,348 million on 31 December 2020.

Net debt/LTM EBITDA denominated both in roubles and US dollars at the end of 9M 2021 was 0.9, against 2.8 on 31 December 2020.

Market Trends

Global urea prices continued to grow in Q3 2021 and surged in Q4 2021. In November 2021, Baltic FOB prices exceeded USD 800, surpassing the 2008 record–high. In some markets they even reached USD 1,000. This rise was driven mainly by limited supply due to an energy crisis in Europe that led several producers to suspend operations. Chinese government actions limiting fertiliser exports also contributed to higher prices. Demand for urea remains strong because of high grain prices, India’s urea purchases, and the start of high season in the Northern Hemisphere. Demand for industrial urea continues to recover, as well.

The continuing growth of AN and UAN prices is supported by higher urea prices, which serve as a benchmark for other nitrogen fertilisers. In November 2021, Baltic FOB prices for these products surpassed USD 600 and beat the 2008 record.

NPK prices continued to climb as well, mainly driven by higher prices for basic products (urea, DAP, and potassium chloride). In November 2021, the price of NPK 16-16-16 hit USD 600, a record high since 2008.

Average Indicative Prices, USD per t, FOB Baltic/Black Sea

NPK 16-16-1642535325320%68%

The full version of Acron Group’s financial statements is available at

Note: The exchange rate used for currency conversion was RUB 72.7608 to USD1 as of 3September2021 and RUB 73.8757 to USD1 as of 31 December2020. The average exchange rate for nine months of 2021 was RUB 74.0073 to USD1. The average exchange rate for nine months of 2020 was RUB70.7778to USD1.

* EBITDA is calculated as operating profit adjusted for depreciation and amortisation, foreign exchange gain or loss on operating transactions, and other non-cash and extraordinary items.

** LTM EBITDA is EBITDA calculated for the past 12 months.

Media Contacts:

Sergey Dorofeev
Anastasia Gromova
Tatiana Smirnova
Public Relations
Phone: +7 (495) 777-08-65 (ext. 5196)

Investor Contacts:

Ilya Popov
Sergey Smirnov
Strategy and Investor Relations
Phone: +7 (495) 745-77-45 (ext. 5252)

Background Information

Acron Group is a leading vertically integrated mineral fertiliser producer in Russia and globally, with chemical production facilities in Veliky Novgorod (Acron) and Smolensk region (Dorogobuzh). The Group owns and operates a phosphate mine in Murmansk region (North-Western Phosphorous Company, NWPC) and is implementing a potash development project in Perm Krai (Verkhnekamsk Potash Company, VPC). It owns transportation and logistics infrastructure, including three Baltic seaport terminals and distribution networks in Russia and China. Acron subsidiary North Atlantic Potash Inc. (NAP) holds mining leases and an exploration permit for ten parcels of the potassium salt deposit at Prairie Evaporite, Saskatchewan, Canada. Acron also holds a minority stake (19.8%) in Polish Grupa Azoty S.A., one of the largest chemical producers in Europe.

In 2020, the Group sold 7.8 million tonnes of its main products to 74 countries, with Russia, Brazil, Europe and the United States as key markets.

In 2020, the Group posted consolidated IFRS revenue of RUB 119,864 million (USD 1,661 million), with EBITDA of RUB 35,311 million (USD 489 million). Acron’s shares are traded on the Moscow Exchange and its global depositary receipts are traded at the London Stock Exchange (ticker AKRN). Acron employs over 11,000 people.

For more information about Acron Group, please visit

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Alation Welcomes Tim Harford OBE as Keynote Speaker at revAlation in London18.8.2022 09:00:00 CEST | Press release

World renowned behavioural economist joins The Very Group CDO to keynote Alation’s industry conference LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Alation Inc., the leader inenterprise data intelligence solutions, today announced that revAlation, its flagship industry conference for data professionals across EMEA, will take place on 4th October and 5th October at County Hall, London. The two-day event will feature data networking opportunities, data training, and keynotes from award winning economist, journalist, and broadcaster Tim Harford, and Chief Data Officer of The Very Group, Steve Pimblett. Tim Harford is a bestselling author of books about economics and data, and the writer of the award-winning Financial Times column, The Undercover Economist. Harford will keynote the event and discuss how to use data and economics in everyday life. Steve Pimblett is the Chief Data Officer at leading UK and Ireland online retailer, The Very Group. Pimblett is an experienced data professional, ha

Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.)18.8.2022 08:30:00 CEST | Press release

SAMPO PLC STOCK EXCHANGE RELEASE 18 August 2022 at 9:30 am Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.) Sampo plc (business code 0142213-3) has received a disclosure under Chapter 9, Section 5 of the Securities Markets Act, according to which the voting rights attached to Sampo A shares (ISIN: FI009003305) owned directly or indirectly by BlackRock, Inc. (USA tax ID 32-0174421) and its funds decreased on 16 August 2022 below five (5) per cent of Sampo plc’s total voting rights. Sampo's share capital comprises 533,261,351 shares, of which 533,061,351 are A shares and 200,000 are B shares. Each A share entitles its holder to one (1) vote and each B share to five (5) votes. Thus, the total number of votes is 534,061,351. Total positions of BlackRock, Inc and its funds subject to the notification: % of shares and voting rights (total of A)% of shares and voting rights through financial instruments (total of B)Total of both in % (A+B)Resultin

Systemair's Interim Report for the first quarter will be presented on August 2518.8.2022 08:00:00 CEST | Press release

Press Release, 18 August 2022 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q1 for the financial year 2022/23 will be published at 13:00 CET on August 25, 2022. A telephone conference will be held at 13:30 CET on August 25, 2022. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference: Call 010-884 8016 alternative international call +44 20 3936 2999 and enter code 539199 minutes before start. The presentation will be published on For further information contact: Roland Kasper, CEO, + 46 73 094 40 13 Anders Ulff, CFO, + 46 70 577 40 09 Systemair AB, SE-739 30 Skinnskatteberg, Sweden, +46 222 440 00, Systemair in brief Systemair is a leading ventilation company with operations in 52 countries in Europe, North America, the Middle East, Asia, Australia and Africa. The Company had sales of SEK 9.6 billion in the 2021/22 financial year and today employs approximately 6,700

Ultimovacs Expands High Dose Cohort Size in TENDU Phase I Prostate Cancer Trial after Safety Review18.8.2022 08:00:00 CEST | Press release

The TENDU interim safety results from nine patients show no safety concernsTrial extended to enroll up to three additional patients at the highest dose levelTENDU designed to evaluate the Tetanus-Epitope Targeting (TET)-platform in patients with prostate cancer Oslo, 18August 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, has completed treatment of three patients at the highest dose cohort in the phase I TENDU trial without any safety concerns. Based on these results, the company plans to enroll up to three additional patients at the highest dose level. The Drug Safety Monitoring Board, a group of experts set up to monitor patient safety during a clinical trial, found no safety concerns in any of the three dose cohorts. A total of nine patients have now been treated; three at each dose level (40 mcg, 400 mcg and 960 mcg). Ultimovacs plans to enroll up to three additional patients at the highest dose level (960 mcg) pro

Systemairs rapport för det första kvartalet presenteras den 25 augusti18.8.2022 08:00:00 CEST | Pressemelding

Pressmeddelande 18 augusti 2022 Systemair ABs (NASDAQ OMX Stockholm: SYSR) delårsrapport Q1 för räkenskapsåret 2022/23 kommer att offentliggöras kl. 13:00 CET den 25 augusti 2022. En telefonkonferens arrangeras kl. 13:30 CET den 25 augusti 2022. Rapporten presenteras av Roland Kasper, CEO, samt Anders Ulff, CFO. För att delta i telefonkonferensen: Ring 010-884 8016 alt. internationellt +44 20 3936 2999 och uppge kod 539199 minuter före start. Presentationen publiceras på För ytterligare information kontakta: Roland Kasper, CEO, + 46 73 094 40 13 Anders Ulff, CFO, + 46 70 577 40 09 Systemair AB, 739 30 Skinnskatteberg, 0222-440 00, Systemair i korthet Systemair är ett ledande ventilationsföretag med verksamhet i 52 länder i Europa, Nordamerika, Mellanöstern, Asien, Australien och Afrika. Bolaget omsatte 9,6 miljarder kronor räkenskapsåret 2021/22 och har idag cirka 6 700 anställda. Sedan grundandet av Systemair 1974 har bolaget uppvisat positiva rör